- Home
- TXN vs PFE Comparison
TXN vs PFE Comparison
Compare TXN & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXN | PFE |
|---|---|---|
| Founded | 1930 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.9B | 155.0B |
| IPO Year | 2000 | 2013 |
Fundamental Metrics
Financial Performance| Metric | TXN | PFE |
|---|---|---|
| Price | $191.85 | $27.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 24 | 12 |
| Target Price | ★ $217.13 | $27.83 |
| AVG Volume (30 Days) | 6.1M | ★ 34.0M |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | 2.87% | ★ 6.46% |
| EPS Growth | ★ 4.81 | N/A |
| EPS | ★ 5.45 | 1.36 |
| Revenue | $17,682,000,000.00 | ★ $62,579,000,000.00 |
| Revenue This Year | $11.66 | N/A |
| Revenue Next Year | $10.41 | N/A |
| P/E Ratio | $36.19 | ★ $19.58 |
| Revenue Growth | ★ 13.05 | N/A |
| 52 Week Low | $139.95 | $20.92 |
| 52 Week High | $231.32 | $27.94 |
Technical Indicators
Market Signals| Indicator | TXN | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 30.63 | 53.01 |
| Support Level | $174.78 | $24.99 |
| Resistance Level | $206.22 | $27.67 |
| Average True Range (ATR) | 5.56 | 0.53 |
| MACD | -3.90 | -0.10 |
| Stochastic Oscillator | 4.94 | 50.00 |
Price Performance
Historical ComparisonAbout TXN Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.